UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1397-1401

2009

Volltextzugriff (PDF)

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Journal of acquired immune deficiency syndromes (1999), 2005-08, Vol.39 (4), p.401-405

2005

Volltextzugriff (PDF)

Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels

Journal of gastroenterology and hepatology, 2012-11, Vol.27 (11), p.1705-1710

2012

Volltextzugriff (PDF)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis

World journal of gastroenterology : WJG, 2019-06, Vol.25 (21), p.2665-2674

2019

Volltextzugriff (PDF)

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

AIDS research and human retroviruses, 2007-08, Vol.23 (8), p.972-982

2007

Volltextzugriff (PDF)

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

AIDS (London), 2008-01, Vol.22 (1), p.15-21

2008

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

The New England journal of medicine, 2014-05, Vol.370 (20), p.1889-1898

2014

Volltextzugriff (PDF)

Management of hepatitis C in HIV-infected persons

Antiviral research, 2001-11, Vol.52 (2), p.189-198

2001

Volltextzugriff (PDF)

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

PloS one, 2016-12, Vol.11 (12), p.e0168544

2016

Volltextzugriff (PDF)

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

The Journal of infection, 2007-02, Vol.54 (2), p.173-179

2007

Volltextzugriff (PDF)

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients

AIDS research and human retroviruses, 2004-04, Vol.20 (4), p.351-353

2004

Volltextzugriff (PDF)

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment

AIDS (London), 2002-02, Vol.16 (3), p.493-495

2002

Volltextzugriff (PDF)

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

The American journal of gastroenterology, 2010-10, Vol.105 (10), p.2164-2172

2010

Volltextzugriff (PDF)

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study

PloS one, 2015-03, Vol.10 (3), p.e0122613-e0122613

2015

Volltextzugriff (PDF)

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study

PloS one, 2019-09, Vol.14 (9), p.e0221567

2019

Volltextzugriff (PDF)

Management of chronic hepatitis C in HIV-infected patients

AIDS (London), 1999-04, Vol.13 (5), p.539-546

1999

Volltextzugriff (PDF)

Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype

The Journal of infectious diseases, 2005-10, Vol.192 (7), p.1245-1248

2005

Volltextzugriff (PDF)

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

AIDS (London), 2006-11, Vol.20 (17), p.2225-2227

2006

Volltextzugriff (PDF)

Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less

Infectious disorders drug targets, 2006-03, Vol.6 (1), p.57-68

2006

Volltextzugriff (PDF)

Update on the treatment of chronic hepatitis C in HIV-infected patients

AIDS reviews, 2007-04, Vol.9 (2), p.99-113

2007

Volltextzugriff (PDF)

New paradigms in the management of HIV and hepatitis C virus coinfection

Current opinion in infectious diseases, 2005-12, Vol.18 (6), p.550-560

2005

Volltextzugriff (PDF)

Emerging drugs for hepatitis C

Expert opinion on emerging drugs, 2008-03, Vol.13 (1), p.1-19

2008

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaAntiviral Agents - Therapeutic Use

ThemaHepatitis C Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Science & Technology
(21)
Life Sciences & Biomedicine
(18)
Ribavirin - Therapeutic Use
(17)
Human Immunodeficiency Virus
(15)
Infectious Diseases
(15)
Hepatitis C
(14)
Hepatitis C, Chronic - Drug Therapy
(14)
Male
(14)
Ribavirin
(14)
Female
(13)
Biological And Medical Sciences
(12)
Interferon-Alpha - Therapeutic Use
(12)
Medical Sciences
(12)
Recombinant Proteins
(12)
Adult
(11)
Hiv
(11)
Hiv Infections - Complications
(11)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Management of hepatitis C in HIV-infected persons

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study

Management of chronic hepatitis C in HIV-infected patients

Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less

Update on the treatment of chronic hepatitis C in HIV-infected patients

New paradigms in the management of HIV and hepatitis C virus coinfection

Emerging drugs for hepatitis C

Aktive Filter

Suchergebnisse filtern